Clinical Trial Update: Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating sacituzumab govitecan in patients with HER2-negative metastatic breast cancer and brain metastases; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer

Drugs mentioned

• Sacituzumab Govitecan (sacituzumab govitecan)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING